Current understanding of metformin effect on the control of hyperglycemia in diabetes

Hongying An, Ling He

Research output: Contribution to journalReview article

Abstract

Metformin is a first-line oral anti-diabetic agent that has been used clinically to treat patients with type 2 diabetes for over 60 years. Due to its efficacy in therapy and affordable price, metformin is taken by more than 150 million people each year. Metformin improves hyperglycemia mainly through the suppression of hepatic gluconeogenesis along with the improvement of insulin signaling. However, its mechanism of action remains partially understood and controversial, especially in regard to the role of AMPK in metformin's action and the mechanism of AMPK activation. In this review, we discuss recent advances in the understanding of metformin's suppression of hepatic glucose production and the mechanism related to the improvement of insulin signaling.

Original languageEnglish (US)
Pages (from-to)R97-R106
JournalJournal of Endocrinology
Volume228
Issue number3
DOIs
StatePublished - Mar 1 2016

Fingerprint

Metformin
Hyperglycemia
AMP-Activated Protein Kinases
Insulin
Gluconeogenesis
Liver
Type 2 Diabetes Mellitus
Glucose

Keywords

  • glucose metabolism
  • insulin action
  • liver
  • metabolism

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Current understanding of metformin effect on the control of hyperglycemia in diabetes. / An, Hongying; He, Ling.

In: Journal of Endocrinology, Vol. 228, No. 3, 01.03.2016, p. R97-R106.

Research output: Contribution to journalReview article

@article{5f4098dffc9f4f1698b5706cd12cc5d1,
title = "Current understanding of metformin effect on the control of hyperglycemia in diabetes",
abstract = "Metformin is a first-line oral anti-diabetic agent that has been used clinically to treat patients with type 2 diabetes for over 60 years. Due to its efficacy in therapy and affordable price, metformin is taken by more than 150 million people each year. Metformin improves hyperglycemia mainly through the suppression of hepatic gluconeogenesis along with the improvement of insulin signaling. However, its mechanism of action remains partially understood and controversial, especially in regard to the role of AMPK in metformin's action and the mechanism of AMPK activation. In this review, we discuss recent advances in the understanding of metformin's suppression of hepatic glucose production and the mechanism related to the improvement of insulin signaling.",
keywords = "glucose metabolism, insulin action, liver, metabolism",
author = "Hongying An and Ling He",
year = "2016",
month = "3",
day = "1",
doi = "10.1530/JOE-15-0447",
language = "English (US)",
volume = "228",
pages = "R97--R106",
journal = "Journal of Endocrinology",
issn = "0022-0795",
publisher = "Society for Endocrinology",
number = "3",

}

TY - JOUR

T1 - Current understanding of metformin effect on the control of hyperglycemia in diabetes

AU - An, Hongying

AU - He, Ling

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Metformin is a first-line oral anti-diabetic agent that has been used clinically to treat patients with type 2 diabetes for over 60 years. Due to its efficacy in therapy and affordable price, metformin is taken by more than 150 million people each year. Metformin improves hyperglycemia mainly through the suppression of hepatic gluconeogenesis along with the improvement of insulin signaling. However, its mechanism of action remains partially understood and controversial, especially in regard to the role of AMPK in metformin's action and the mechanism of AMPK activation. In this review, we discuss recent advances in the understanding of metformin's suppression of hepatic glucose production and the mechanism related to the improvement of insulin signaling.

AB - Metformin is a first-line oral anti-diabetic agent that has been used clinically to treat patients with type 2 diabetes for over 60 years. Due to its efficacy in therapy and affordable price, metformin is taken by more than 150 million people each year. Metformin improves hyperglycemia mainly through the suppression of hepatic gluconeogenesis along with the improvement of insulin signaling. However, its mechanism of action remains partially understood and controversial, especially in regard to the role of AMPK in metformin's action and the mechanism of AMPK activation. In this review, we discuss recent advances in the understanding of metformin's suppression of hepatic glucose production and the mechanism related to the improvement of insulin signaling.

KW - glucose metabolism

KW - insulin action

KW - liver

KW - metabolism

UR - http://www.scopus.com/inward/record.url?scp=84975744759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975744759&partnerID=8YFLogxK

U2 - 10.1530/JOE-15-0447

DO - 10.1530/JOE-15-0447

M3 - Review article

VL - 228

SP - R97-R106

JO - Journal of Endocrinology

JF - Journal of Endocrinology

SN - 0022-0795

IS - 3

ER -